Latest News & Updates

Breaking News

  • 2 hours ago

  • Vaibhavi M.

Kiora Appoints Retina Leader Dr. Taiji Sakamoto To Scientific Advisory Board, Strengthens Retina Pipeline
Breaking News
Eyestem Receives CDSCO Approval to Initiate Phase 2 Randomized, Controlled Human Trials of Eyecyte-RPE™

Team Pharma Now

Other trending news you may like to read

Kiora Appoints Retina Leader Dr. Taiji Sakamoto To Scientific Advisory Board, Strengthens Retina Pipeline

Kiora names leading retina expert Dr. Taiji Sakamoto to its Scientific Advisory Board as it advances non-steroidal retinal therapies.

Vaibhavi M.

Pharma Now

Eyestem Receives CDSCO Approval to Initiate Phase 2 Randomized, Controlled Human Trials of Eyecyte-RPE™

Eyestem receives CDSCO approval to begin Phase 2 trials of Eyecyte-RPE for geographic atrophy in dry age-related macular degeneration.

Team Pharma Now

Pharma Now

GRI Bio Secures New U.S. Patent For Novel Immunomodulatory Compound Compositions Targeting Inflammatory, Fibrotic, And Autoimmune Diseases

GRI Bio expands its IP portfolio with a newly issued US patent supporting its NKT cell immunomodulation platform.

Simantini Singh Deo

Pharma Now

Cogent Biosciences Secures FDA Breakthrough Therapy Status For Bezuclastinib + Sunitinib Combo To Treat Gastrointestinal Stromal Tumors (GIST)

Cogent’s bezuclastinib–sunitinib combo receives FDA Breakthrough designation for treating advanced GIST after imatinib.

Simantini Singh Deo

Pharma Now